A quick overview
10
Before we get to the updates- first, thank you so much for subscribing to the premium site! Second, a quick housekeeping. This month’s housekeeping has…
4
Dave Johnson from Caligan Partners discusses his thesis on Evolus (EOLS). Evolus is a one product company. Their product, Jeuveau, is a Botox competitor…
5
One theme I’ve been obsessed with this year is cyclicals trading at low multiples. There’s an old adage that the time to buy cyclicals is when their…
4
Chris DeMuth joins the podcast to discuss the state of the markets in September 2022 and what’s catching his eye in event driven land, including an…
14
2
The team from CoVest discusses why they launched CoVest and then dives deep into their thesis for OEC. You can learn more about CoVest here. Please…
12
2
Dave Waters from Alluvial Capital returns to the podcast to discuss his thesis on PX. You can find Dave’s first appearance (back in the absolute depths…
12
2
James Elbaor, founder and CIO of Marlton Capital, discusses his investment thesis for Pershing Square Holdings (PSH). Please follow the podcast on…
12
3
See all

Yet Another Value Blog